{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:47:57Z","timestamp":1793296077558,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["L234008"],"award-info":[{"award-number":["L234008"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72374153"],"award-info":[{"award-number":["72374153"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tianjin Medical Key Discipline Project","award":["TJYXZDXK-050A"],"award-info":[{"award-number":["TJYXZDXK-050A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Tianjin, a major hub in northern China, faces rising HIV-1 infections dominated by CRF01_AE and CRF07_BC. This study elucidated their divergent transmission patterns and drug resistance dynamics to guide targeted interventions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This study included samples identified as CRF01_AE and CRF07_BC subtypes through various methods between 2013 and 2022. BEAST software was used to examine the spatiotemporal transmission patterns of these subtypes in Tianjin. By integrating HIV-TRACE, we constructed high-risk transmission clusters and identified drug resistance mutations (DRMs) based on the Stanford HIV Drug Resistance Database. Finally, the birth\u2013death skyline serial (BDSKY) model was employed to dynamically assess the effective reproductive number (Re) of both subtypes to predict future transmission dynamics.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>CRF01_AE might be introduced in 1988 from Henan and Zhejiang, forming multiple small clusters (&lt;\u200910 nodes) and spreading through both heterosexual and men who have sex with men (MSM) in Tianjin, while CRF07_BC from Chongqing and Guizhou, et al. in 2004, experiencing explosive local transmission and forming a large cluster of 170 nodes primarily among MSM under 30\u00a0years old (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Phylogenetic analysis indicated that CRF01_AE has a significantly higher evolutionary rate (2.08\u2009\u00d7\u200910\u207b<jats:sup>3<\/jats:sup> vs. 1.48\u2009\u00d7\u200910\u207b<jats:sup>3<\/jats:sup> substitutions\/site\/year, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05), while CRF07_BC demonstrates a greater cluster formation capacity (56.6% vs. 37.1%, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). CRF01_AE showed a higher mutation occurrence rate (5.18% vs. 2.49%, P\u2009&lt;\u20090.05), particularly with non-nucleoside reverse transcriptase inhibitor (NNRTI) associated mutations (e.g., K101E). Although CRF07_BC had a lower resistance burden, the emergence of K103E mutations suggests a need for vigilance regarding potential decreases in sensitivity to newer NNRTIs. BDSKY modeling revealed that the Re for CRF01_AE dropped below 1 after 2016, whereas CRF07_BC\u2019s Re remains above 1, indicating that the risk of transmission still exists.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Subtype-specific strategies are critical: intensified resistance monitoring for CRF01_AE and cluster-focused interventions for CRF07_BC, particularly among young MSM.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12985-025-02704-y","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T18:35:06Z","timestamp":1746729306000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Divergent transmission dynamics and drug resistance evolution of HIV-1 CRF01_AE and CRF07_BC in Tianjin, China (2013\u20132022)"],"prefix":"10.1186","volume":"22","author":[{"given":"Zheng","family":"Minna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Hehe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Tielin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Fangning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gong","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Maohe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"key":"2704_CR1","unstructured":"UNAIDS, Global HIV & AIDS statistics: 2022 fact sheet. 2022"},{"issue":"48","key":"2704_CR2","first-page":"1257","volume":"6","author":"YF Dong Wang","year":"2024","unstructured":"Dong Wang YF, Hao J, Hongping Hu, Li F, Li J, Ruan Y, Liao L, Jing Hu, Song C, Shao Y, Xing H. National and regional molecular epidemiology of hiv-1: China, 2004\u20132023. China CDC Weekly. 2024;6(48):1257\u201363.","journal-title":"China CDC Weekly"},{"key":"2704_CR3","unstructured":"Prevention, C.f.D.C.a., HIV Surveillance Report, 2021. 2023. 34"},{"issue":"11","key":"2704_CR4","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1097\/QAD.0b013e328360db2d","volume":"27","author":"Y Feng","year":"2013","unstructured":"Feng Y, et al. The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s. AIDS. 2013;27(11):1793\u2013802.","journal-title":"AIDS"},{"key":"2704_CR5","doi-asserted-by":"publisher","first-page":"19279","DOI":"10.1038\/srep19279","volume":"6","author":"Y Feng","year":"2016","unstructured":"Feng Y, et al. Geographic origin and evolutionary history of China\u2019s two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC. Sci Rep. 2016;6:19279.","journal-title":"Sci Rep"},{"issue":"1","key":"2704_CR6","doi-asserted-by":"publisher","first-page":"veac014","DOI":"10.1093\/ve\/veac014","volume":"8","author":"X Li","year":"2022","unstructured":"Li X, et al. The emergence and transmission dynamics of HIV-1 CRF07_BC in Mainland China. Virus Evol. 2022;8(1):veac014.","journal-title":"Virus Evol"},{"key":"2704_CR7","doi-asserted-by":"publisher","first-page":"1179568","DOI":"10.3389\/fpubh.2023.1179568","volume":"11","author":"Y Xu","year":"2023","unstructured":"Xu Y, et al. Transmitted drug resistance and transmission clusters among ART-na\u00efve HIV-1-infected individuals from 2019 to 2021 in Nanjing. China Front Public Health. 2023;11:1179568.","journal-title":"China Front Public Health"},{"issue":"1","key":"2704_CR8","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1080\/22221751.2022.2119167","volume":"11","author":"Q Fan","year":"2022","unstructured":"Fan Q, et al. Molecular genetics and epidemiological characteristics of HIV-1 epidemic strains in various sexual risk behaviour groups in developed Eastern China, 2017\u20132020. Emerg Microbes Infect. 2022;11(1):2326\u201339.","journal-title":"Emerg Microbes Infect"},{"issue":"8","key":"2704_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29824","volume":"96","author":"Z Hehe","year":"2024","unstructured":"Hehe Z, et al. Application of molecular epidemiology in revealing HIV-1 transmission network and recombination patterns in Tianjin, China. J Med Virol. 2024;96(8): e29824.","journal-title":"J Med Virol"},{"issue":"18","key":"2704_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku739","volume":"42","author":"D Struck","year":"2014","unstructured":"Struck D, et al. COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification. Nucleic Acids Res. 2014;42(18): e144.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2704_CR11","doi-asserted-by":"publisher","first-page":"vey016","DOI":"10.1093\/ve\/vey016","volume":"4","author":"MA Suchard","year":"2018","unstructured":"Suchard MA, et al. Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10. Virus Evol. 2018;4(1):vey016.","journal-title":"Virus Evol"},{"issue":"1","key":"2704_CR12","doi-asserted-by":"publisher","first-page":"vew007","DOI":"10.1093\/ve\/vew007","volume":"2","author":"A Rambaut","year":"2016","unstructured":"Rambaut A, et al. Exploring the temporal structure of heterochronous sequences using TempEst (formerly Path-O-Gen). Virus Evol. 2016;2(1):vew007.","journal-title":"Virus Evol"},{"issue":"5","key":"2704_CR13","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/sysbio\/syy032","volume":"67","author":"A Rambaut","year":"2018","unstructured":"Rambaut A, et al. Posterior summarization in bayesian phylogenetics using tracer 1.7. Syst Biol. 2018;67(5):901\u20134.","journal-title":"Syst Biol"},{"issue":"W1","key":"2704_CR14","doi-asserted-by":"publisher","first-page":"W293","DOI":"10.1093\/nar\/gkab301","volume":"49","author":"I Letunic","year":"2021","unstructured":"Letunic I, Bork P. Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res. 2021;49(W1):W293-w296.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"2704_CR15","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1093\/molbev\/msw082","volume":"33","author":"F Bielejec","year":"2016","unstructured":"Bielejec F, et al. Sprea D3: interactive visualization of spatiotemporal history and trait evolutionary processes. Mol Biol Evol. 2016;33(8):2167\u20139.","journal-title":"Mol Biol Evol"},{"issue":"7","key":"2704_CR16","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1093\/molbev\/msy016","volume":"35","author":"SL Kosakovsky Pond","year":"2018","unstructured":"Kosakovsky Pond SL, et al. HIV-TRACE (TRAnsmission Cluster Engine): a tool for large scale molecular epidemiology of hiv-1 and other rapidly evolving pathogens. Mol Biol Evol. 2018;35(7):1812\u20139.","journal-title":"Mol Biol Evol"},{"issue":"1","key":"2704_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/molbev\/msz197","volume":"37","author":"SL Kosakovsky Pond","year":"2020","unstructured":"Kosakovsky Pond SL, et al. HyPhy 2.5-a customizable platform for evolutionary hypothesis testing using phylogenies. Mol Biol Evol. 2020;37(1):295\u20139.","journal-title":"Mol Biol Evol"},{"issue":"8","key":"2704_CR18","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1097\/QAD.0b013e3283388742","volume":"24","author":"WH Wheeler","year":"2010","unstructured":"Wheeler WH, et al. Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.-2006. AIDS. 2010;24(8):1203\u201312.","journal-title":"AIDS"},{"issue":"4","key":"2704_CR19","doi-asserted-by":"publisher","first-page":"e1006650","DOI":"10.1371\/journal.pcbi.1006650","volume":"15","author":"R Bouckaert","year":"2019","unstructured":"Bouckaert R, et al. BEAST 2.5: an advanced software platform for Bayesian evolutionary analysis. PLoS Comput Biol. 2019;15(4):e1006650.","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"2704_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/molbev\/msr217","volume":"29","author":"T Stadler","year":"2012","unstructured":"Stadler T, et al. Estimating the basic reproductive number from viral sequence data. Mol Biol Evol. 2012;29(1):347\u201357.","journal-title":"Mol Biol Evol"},{"key":"2704_CR21","unstructured":"DETECTING AND RESPONDING TO HIV Transmission Clusters: A GUIDE HEALTH DEPARTMENTS. 2018 [cited 2024 January]; Available from: https:\/\/www.cdc.gov\/hiv\/pdf\/funding\/announcements\/ps18-1802\/CDC-HIV-PS18-1802-AttachmentE-Detecting-Investigating-and-Responding-to-HIV-Transmission-Clusters.pdf."},{"issue":"5","key":"2704_CR22","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1089\/aid.2015.0212","volume":"32","author":"H Zeng","year":"2016","unstructured":"Zeng H, et al. The epidemic dynamics of four major lineages of HIV-1 CRF01_AE Strains after their introduction into China. AIDS Res Hum Retroviruses. 2016;32(5):420\u20136.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"18","key":"2704_CR23","doi-asserted-by":"publisher","first-page":"9206","DOI":"10.1128\/JVI.00399-08","volume":"82","author":"KK Tee","year":"2008","unstructured":"Tee KK, et al. Temporal and spatial dynamics of human immunodeficiency virus type 1 circulating recombinant forms 08_BC and 07_BC in Asia. J Virol. 2008;82(18):9206\u201315.","journal-title":"J Virol"},{"issue":"3","key":"2704_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/COH.0000000000000534","volume":"14","author":"N Bbosa","year":"2019","unstructured":"Bbosa N, Kaleebu P, Ssemwanga D. HIV subtype diversity worldwide. Curr Opin HIV AIDS. 2019;14(3):153\u201360.","journal-title":"Curr Opin HIV AIDS"},{"issue":"1","key":"2704_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12985-023-02112-0","volume":"20","author":"T Tan","year":"2023","unstructured":"Tan T, et al. HIV-1 molecular transmission network and drug resistance in Chongqing, China, among men who have sex with men (2018\u20132021). Virol J. 2023;20(1):147.","journal-title":"Virol J"},{"issue":"30","key":"2704_CR26","doi-asserted-by":"publisher","first-page":"664","DOI":"10.46234\/ccdcw2023.129","volume":"5","author":"X Liu","year":"2023","unstructured":"Liu X, et al. Changes in HIV-1 subtypes\/sub-subtypes, and transmitted drug resistance among ART-na\u00efve HIV-infected individuals - China, 2004\u20132022. China CDC Wkly. 2023;5(30):664\u201371.","journal-title":"China CDC Wkly"},{"issue":"3","key":"2704_CR27","doi-asserted-by":"publisher","first-page":"ofab051","DOI":"10.1093\/ofid\/ofab051","volume":"8","author":"Q Fan","year":"2021","unstructured":"Fan Q, et al. Analysis of the driving factors of active and rapid growth clusters among CRF07_BC-infected patients in a developed area in Eastern China. Open Forum Infect Dis. 2021;8(3):ofab051.","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"2704_CR28","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1186\/s12879-019-4559-1","volume":"19","author":"MJ Dong","year":"2019","unstructured":"Dong MJ, et al. The prevalence of HIV among MSM in China: a large-scale systematic analysis. BMC Infect Dis. 2019;19(1):1000.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"2704_CR29","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1089\/aid.2016.0029","volume":"32","author":"X Li","year":"2016","unstructured":"Li X, et al. Nationwide trends in molecular epidemiology of HIV-1 in China. AIDS Res Hum Retroviruses. 2016;32(9):851\u20139.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2704_CR30","unstructured":"World Health Organization. Guidelines on the public health response to pretreatment HIV drug resistance. 2016"},{"issue":"6","key":"2704_CR31","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s15010-021-01668-9","volume":"49","author":"Z Yang","year":"2021","unstructured":"Yang Z, et al. Prevalence of integrase strand transfer inhibitor (INSTIs) resistance mutations in Henan Province, China (2018\u20132020). Infection. 2021;49(6):1195\u2013202.","journal-title":"Infection"},{"issue":"2","key":"2704_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.46234\/ccdcw2025.007","volume":"7","author":"H Hu","year":"2025","unstructured":"Hu H, et al. Pretreatment HIV drug resistance to integrase strand transfer inhibitors among newly diagnosed HIV Individuals - China, 2018\u20132023. China CDC Wkly. 2025;7(2):31\u20139.","journal-title":"China CDC Wkly"},{"key":"2704_CR33","first-page":"195","volume":"15","author":"F Yu","year":"2022","unstructured":"Yu F, et al. Drug resistance to HIV-1 integrase inhibitors among treatment-naive patients in Beijing. China Pharmgenomics Pers Med. 2022;15:195\u2013203.","journal-title":"China Pharmgenomics Pers Med"},{"key":"2704_CR34","doi-asserted-by":"crossref","unstructured":"Fan, Q., et al., Insights into the molecular network characteristics of major HIV-1 subtypes in developed Eastern China: a study based on comprehensive molecular surveillance data. Infection, 2024.","DOI":"10.1007\/s15010-024-02389-5"},{"key":"2704_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102859","volume":"77","author":"L Ge","year":"2024","unstructured":"Ge L, et al. Global, regional, and national prevalence of HIV-1 drug resistance in treatment-naive and treatment-experienced children and adolescents: a systematic review and meta-analysis. EClinicalMedicine. 2024;77: 102859.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"2704_CR36","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11904-019-00478-x","volume":"17","author":"W Cao","year":"2020","unstructured":"Cao W, Hsieh E, Li T. Optimizing treatment for adults with HIV\/AIDS in China: successes over two decades and remaining challenges. Curr HIV\/AIDS Rep. 2020;17(1):26\u201334.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"2704_CR37","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1080\/22221751.2021.1978822","volume":"10","author":"Z Ge","year":"2021","unstructured":"Ge Z, et al. HIV-1 CRF07_BC transmission dynamics in China: two decades of national molecular surveillance. Emerg Microbes Infect. 2021;10(1):1919\u201330.","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"2704_CR38","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/v13010116","volume":"13","author":"I Alexiev","year":"2021","unstructured":"Alexiev I, et al. Molecular epidemiological analysis of the origin and transmission dynamics of the HIV-1 CRF01_AE sub-epidemic in Bulgaria. Viruses. 2021;13(1):116.","journal-title":"Viruses"},{"key":"2704_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.824178","volume":"13","author":"M Gan","year":"2022","unstructured":"Gan M, et al. Spatiotemporal patterns of CRF07_BC in China: a population-based study of the HIV strain with the highest infection rates. Front Immunol. 2022;13: 824178.","journal-title":"Front Immunol"},{"issue":"1","key":"2704_CR40","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12879-019-3788-7","volume":"19","author":"PP Zhou","year":"2019","unstructured":"Zhou PP, et al. Rapid and complicated HIV genotype expansion among high-risk groups in Guangdong Province, China. BMC Infect Dis. 2019;19(1):185.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"2704_CR41","doi-asserted-by":"publisher","first-page":"6330","DOI":"10.1038\/s41598-017-06573-6","volume":"7","author":"X Wang","year":"2017","unstructured":"Wang X, et al. Phylodynamics of major CRF01_AE epidemic clusters circulating in mainland of China. Sci Rep. 2017;7(1):6330.","journal-title":"Sci Rep"},{"key":"2704_CR42","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00683-20","author":"B Vrancken","year":"2020","unstructured":"Vrancken B, et al. Comparative circulation dynamics of the five main HIV types in China. J Virol. 2020. https:\/\/doi.org\/10.1128\/JVI.00683-20.","journal-title":"J Virol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02704-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02704-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02704-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T18:35:11Z","timestamp":1746729311000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02704-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2704"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02704-y","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"assertion":[{"value":"6 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Review Committee (Ethical Review Number: X231028769) of the National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"137"}}